Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$45.44 - $74.26 $545 - $891
-12 Reduced 0.19%
6,337 $416,000
Q4 2022

Jan 23, 2023

SELL
$41.39 - $81.0 $3,104 - $6,075
-75 Reduced 1.17%
6,349 $0
Q3 2022

Oct 18, 2022

SELL
$72.36 - $113.1 $795 - $1,244
-11 Reduced 0.17%
6,424 $465,000
Q2 2022

Jul 18, 2022

SELL
$87.2 - $114.05 $5,493 - $7,185
-63 Reduced 0.97%
6,435 $690,000
Q1 2022

May 10, 2022

BUY
$94.19 - $124.49 $381,846 - $504,682
4,054 Added 165.88%
6,498 $721,000
Q4 2021

Feb 02, 2022

SELL
$119.57 - $139.07 $3,945 - $4,589
-33 Reduced 1.33%
2,444 $313,000
Q3 2021

Oct 29, 2021

SELL
$109.17 - $142.35 $327 - $427
-3 Reduced 0.12%
2,477 $330,000
Q2 2021

Aug 04, 2021

SELL
$100.34 - $115.69 $3,612 - $4,164
-36 Reduced 1.43%
2,480 $268,000
Q1 2021

May 10, 2021

SELL
$101.51 - $125.27 $34,817 - $42,967
-343 Reduced 12.0%
2,516 $265,000
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $55,306 - $67,851
-644 Reduced 18.38%
2,859 $298,000
Q3 2020

Nov 12, 2020

SELL
$72.74 - $92.5 $71,430 - $90,835
-982 Reduced 21.9%
3,503 $300,000
Q2 2020

Jul 30, 2020

SELL
$48.02 - $79.04 $103,531 - $170,410
-2,156 Reduced 32.46%
4,485 $329,000
Q1 2020

May 07, 2020

SELL
$36.95 - $62.95 $480 - $818
-13 Reduced 0.2%
6,641 $345,000
Q4 2019

Feb 07, 2020

BUY
$47.06 - $56.64 $66,072 - $79,522
1,404 Added 26.74%
6,654 $375,000
Q3 2019

Nov 12, 2019

SELL
$47.45 - $58.05 $2,514 - $3,076
-53 Reduced 1.0%
5,250 $250,000
Q2 2019

Jul 26, 2019

BUY
$39.26 - $54.21 $208,195 - $287,475
5,303 New
5,303 $287,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.